Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation

OBJECTIVE: Serum procollagen type I N-terminal propeptide (PINP), a representative marker of bone anabolic action, is strongly related to bone mineral density during teriparatide therapy. This post hoc study analyzed data from a Phase III study (ClinicalTrials.gov identifier NCT00433160) to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Takanori, Tsujimoto, Mika, Sowa, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500620/
https://www.ncbi.nlm.nih.gov/pubmed/26185429
http://dx.doi.org/10.2147/CIA.S83549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500620/
https://www.ncbi.nlm.nih.gov/pubmed/26185429
http://dx.doi.org/10.2147/CIA.S83549

Ejemplares similares